Skip to content
akaturk Academic measurement

Academician profile · PROFESÖR

ÖZLEM KESKİN

GAZİANTEP ÜNİVERSİTESİ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Çocuk İmmünolojisi ve Allerji Hastalıkları (Çocuk Sağlığı ve Hastalıkları)
  • TIP FAKÜLTESİ
  • DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Articles YÖKSİS 137
Projects 1
Books 8
Proceedings 82
Patents 1
Artistic 1
Scopus (SJR)
Q1 65 Q2 23 Q3 14 Q4 12
WoS (JCR)
Q1 30 Q2 39 Q3 22 Q4 22
TR Index 22 articles

Scopus (SJR)

Q1 65 Q2 23 Q3 14 Q4 12

WoS (JCR)

Q1 30 Q2 39 Q3 22 Q4 22

TR Index

22 articles

137 publications total

Articles

  1. 2025 Clinical, laboratory, and molecular characteristics of patients with spondyloenchondrodysplasia: a case series study European Journal of Pediatrics DOI 10.1007/s00431-025-05982-4
  2. 2025 Role of Matsuda Index in Identifying Patients at Risk for Cystic Fibrosis-Related Diabetes Development Children DOI 10.3390/children12111566
  3. 2025 Evaluation of clinical and genetic characteristics of cystic fibrosis patients in the Southeastern Anatolia of Turkey Pediatrics International DOI 10.1111/ped.70197
  4. 2025 Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey Pediatric Pulmonology DOI 10.1002/ppul.71155
  5. 2025 Evaluation of clinical and genetic characteristics of cystic fibrosis patients in the Southeastern Anatolia of Turkey Pediatrics International DOI 10.1111/ped.70197
  6. 2025 Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast Treatment Journal of Paediatrics and Child Health DOI 10.1111/jpc.70092
  7. 2025 National Registry for Home Mechanical Ventilation in Children from Turkey Respiration DOI 10.1159/000543343
  8. 2025 Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye. Turk J Pediatr. DOI 10.24953/turkjpediatr.2025.4680.
  9. 2025 Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye. Turk J Pediatr. DOI 10.24953/turkjpediatr.2025.4680
  10. 2025 A retrospective cohort study of children diagnosed with Cystic Fibrosis after implementation of a newborn screening program in Turkey Repiratory Medicine DOI 10.1016/j.rmed.2025.108047
  11. 2025 A retrospective cohort study of children diagnosed with Cystic Fibrosis after implementation of a newborn screening program in Turkey Respiratory Medicine DOI 10.1016/j.rmed.2025.108047
  12. 2025 A retrospective cohort study of children diagnosed with Cystic Fibrosis after implementation of a newborn screening program in Turkey Respiratory Medicine DOI 10.1016/j.rmed.2025.108047.
  13. 2025 A retrospective cohort study of children diagnosed with Cystic Fibrosis after implementation of a newborn screening program in Turkey Respiratory Medicine DOI 10.1016/j.rmed.2025.108047
  14. 2025 Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey Pediatric Pulmonology DOI 10.1002/ppul.71155
  15. 2025 Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast Treatment Journal of Paediatrics and Child Health DOI 10.1111/jpc.70092
  16. 2025 Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey Pediatric Pulmonology DOI 10.1002/ppul.71155
  17. 2025 Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye The Turkish Journal of Pediatrics DOI 10.24953/turkjpediatr.2025.4680
  18. 2025 Current Status of Cystic Fibrosis in Türkiye: Data from the National Registry Thoracic Research and Practice DOI 10.4274/ThoracResPract.2025.2025-1-11
  19. 2025 FROM THE EDITOR 2025, April, Volume 23, Issue 1 Asthma Allergy Immunology DOI 10.21911/aai.2025.011
  20. 2025 Sesame Sensitization in Children with Allergic Symptoms: Prevalence and Associated Allergic Conditions Asthma Allergy Immunology DOI 10.21911/aai.2025.799

Back to academicians